Evolving Regulations and Guidelines in Genetic Testing
Understanding the regulatory landscape of genetic and genomic testing, and its impact on clinical practice
Understanding the regulatory landscape of genetic and genomic testing, and its impact on clinical practice
How three companies are addressing screening challenges with tests that help improve chances of early detection
Recent enforcement actions involved usual targets such as COVID-19, genetic, and urine drug testing, but EKRA also made an appearance
This Lab Institute presentation shares recent enforcement trends and how labs can avoid compliance risks related to these issues.
With the global cancer burden growing, is a universal germline genomic testing approach the key to more effectively combating the disease?